Recombivax HB Dialysis Formulation Interactions
There are 280 drugs known to interact with Recombivax HB Dialysis Formulation (hepatitis b adult vaccine), along with 1 disease interaction. Of the total drug interactions, 1 is major, 277 are moderate, and 2 are minor.
- View all 280 medications that may interact with Recombivax HB Dialysis Formulation
- View Recombivax HB Dialysis Formulation disease interactions (1)
Most frequently checked interactions
View interaction reports for Recombivax HB Dialysis Formulation (hepatitis b adult vaccine) and the medicines listed below.
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir disoproxil)
- Advate (antihemophilic factor)
- Aspirin Low Strength (aspirin)
- Avandia (rosiglitazone)
- Azithromycin Dose Pack (azithromycin)
- Brilinta (ticagrelor)
- calcium carbonate
- captopril
- Cipro (ciprofloxacin)
- clonidine
- Coreg (carvedilol)
- Cozaar (losartan)
- digoxin
- Epogen (epoetin alfa)
- fentanyl
- Gammagard S/D (immune globulin intravenous)
- gentamicin
- heparin
- hydralazine
- hydroxyzine
- Imdur (isosorbide mononitrate)
- isosorbide mononitrate
- Keveyis (dichlorphenamide)
- Koate-HP (antihemophilic factor)
- Lipitor (atorvastatin)
- lisinopril
- lovastatin / niacin
- meropenem
- mexiletine
- omeprazole / sodium bicarbonate
Recombivax HB Dialysis Formulation disease interactions
There is 1 disease interaction with Recombivax HB Dialysis Formulation (hepatitis b adult vaccine) which include:
More about Recombivax HB Dialysis Formulation (hepatitis b adult vaccine)
- Recombivax HB Dialysis Formulation consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.